• PMV Pharmaceuticals named Matt Eckler to its board of directors.
• Eckler is a principal at Samsara BioCapital, leading its public equity strategy.
• He previously held investment roles at ArrowMark Partners, GMT Capital, and RBC Capital Markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMV Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050800PRIMZONEFULLFEED9838846) on October 05, 2026, and is solely responsible for the information contained therein.